Free Trial

Cencora (COR) Competitors

Cencora logo
$299.48 +0.06 (+0.02%)
As of 03:58 PM Eastern

COR vs. MCK, CAH, HSIC, PDCO, OMI, DHR, CVS, ELV, NTRA, and LH

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Elevance Health (ELV), Natera (NTRA), and Labcorp (LH). These companies are all part of the "medical" sector.

Cencora vs. Its Competitors

McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.7%. McKesson pays out 11.0% of its earnings in the form of a dividend. Cencora pays out 25.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years and Cencora has increased its dividend for 15 consecutive years.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$359.05B0.26$3.30B$25.8328.36
Cencora$293.96B0.20$1.51B$8.6234.74

McKesson presently has a consensus target price of $696.42, suggesting a potential downside of 4.93%. Cencora has a consensus target price of $306.33, suggesting a potential upside of 2.29%. Given Cencora's higher probable upside, analysts clearly believe Cencora is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86
Cencora
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.82

85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 10.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

McKesson has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500.

In the previous week, McKesson had 7 more articles in the media than Cencora. MarketBeat recorded 41 mentions for McKesson and 34 mentions for Cencora. Cencora's average media sentiment score of 1.49 beat McKesson's score of 1.32 indicating that Cencora is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
33 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cencora
29 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson has a net margin of 0.92% compared to Cencora's net margin of 0.55%. Cencora's return on equity of 344.71% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.92% -201.12% 5.83%
Cencora 0.55%344.71%4.26%

Summary

McKesson beats Cencora on 12 of the 20 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$58.05B$7.39B$5.46B$20.33B
Dividend Yield0.73%2.80%5.36%3.78%
P/E Ratio34.7428.2526.4627.52
Price / Sales0.2034.05404.5438.36
Price / Cash15.0618.5725.8817.85
Price / Book74.136.457.924.54
Net Income$1.51B$230.16M$3.15B$985.09M
7 Day Performance2.19%1.95%2.20%1.70%
1 Month Performance2.74%4.98%4.39%4.05%
1 Year Performance32.92%30.68%32.26%12.20%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
4.6419 of 5 stars
$299.48
+0.0%
$306.33
+2.3%
+33.0%$58.05B$293.96B34.7442,000Positive News
Analyst Forecast
MCK
McKesson
4.6922 of 5 stars
$722.44
+0.2%
$694.38
-3.9%
+24.3%$90.39B$359.05B27.9745,000Positive News
Analyst Upgrade
CAH
Cardinal Health
4.7921 of 5 stars
$163.95
+0.3%
$157.43
-4.0%
+70.0%$39.13B$226.83B25.5848,900Positive News
HSIC
Henry Schein
2.8019 of 5 stars
$71.89
-0.1%
$79.30
+10.3%
+14.3%$8.75B$12.67B22.4725,000
PDCO
Patterson Companies
1.6131 of 5 stars
$31.33
flat
$26.57
-15.2%
N/A$2.77B$6.51B18.327,700
OMI
Owens & Minor
4.3488 of 5 stars
$7.28
-0.8%
$12.33
+69.4%
-34.1%$562.38M$10.70B-1.5323,200
DHR
Danaher
4.9467 of 5 stars
$196.49
+0.0%
$248.17
+26.3%
-20.7%$140.62B$23.88B38.1563,000Positive News
Analyst Upgrade
CVS
CVS Health
4.8971 of 5 stars
$66.93
+0.5%
$75.07
+12.2%
+16.0%$84.67B$372.81B15.97300,000Analyst Forecast
ELV
Elevance Health
4.8875 of 5 stars
$372.53
-0.5%
$498.87
+33.9%
-29.6%$84.17B$177.01B14.54104,200
NTRA
Natera
1.3357 of 5 stars
$170.37
-0.9%
$184.63
+8.4%
+55.1%$23.26B$1.70B-115.904,434Positive News
LH
Labcorp
4.4399 of 5 stars
$261.01
-0.3%
$274.00
+5.0%
+27.9%$21.85B$13.01B30.1770,000Positive News

Related Companies and Tools


This page (NYSE:COR) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners